StrategyGilead Backtracks on Orphan Drug Designation for Remdesivir
NIH is testing the antiviral drug's safety and efficacy against COVID-19.
StrategyDoctors Are Hoarding Unproven Coronavirus Medicine by Writing Prescriptions for Themselves and Their Families
Demand for chloroquine and hydroxychloroquine surged over the past several days as President Donald Trump promoted them as possible treatments...
FinanceAllergan Reduces Operating Loss by 29%, Revenues Tick Up
The Dublin-based drugmaker improved on most financial metrics during 2019.
StrategyCMS Proposes 0.93% Pay Rate Hike for MA Plans in 2021
The rate hike is part of a broader package of proposed "refinements" for Medicare Advantage and the Part D Quality...
FinanceBristol-Myers Squibb Revenues Top $26B, EPS Falls 33%
The New York-based drugmaker also saw U.S. revenues rise 42% in Q4 2019.
FinanceWorldwide Sales for Merck Nearly Reach $47B
The Kenilworth, New Jersey?based drugmaker also announced plans to spin off three segments into a new company.
FinancePfizer Revenues Slide to End 2019
The New York-based drugmaker projects its 2020 revenues will be between $48.5 billion to $50.5 billion.
FinanceFTC, NY AG Charge 'Pharma Bro' Martin Shkreli and Vyera Pharmaceuticals in Daraprim Price Scheme
Martin Shkreli, nicknamed the 'pharma bro,' was sentenced to seven years in prison for securities fraud in 2018.
Clinical CareCVS Health Targets 2020 Healthcare Trends
CVS Health and its corporate partner Aetna have launched initiatives to take on some of the most daunting challenges in...
FinanceDOJ Joins Fraud Suit Against CVS, Omnicare
The lawsuit alleges that Omnicare billed Medicare and other government-sponsored health plans for hundreds of thousands of invalid prescriptions.
StrategyHouse Passes Pelosi Drug-Pricing Bill
The Lower Drug Costs Now Act is unlikely to advance past the Senate.
StrategyHouse Set to Vote on Pelosi Drug Pricing Plan
The plan has garnered attention and debate since it was first introduced in September.